These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29438352)

  • 1. The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic.
    Davidsson M
    Healthcare (Basel); 2018 Feb; 6(1):. PubMed ID: 29438352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group.
    Shor S; Green C; Szantyr B; Phillips S; Liegner K; Burrascano JJ; Bransfield R; Maloney EL
    Antibiotics (Basel); 2019 Dec; 8(4):. PubMed ID: 31888310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epidemiological disease burden and annual health insurance treatment cost of colorectal cancer in Hungary].
    Kívés Z; Endrei D; Elmer D; Csákvári T; Kajos LF; Boncz I; Mangel L; Mihály-Vajda R
    Orv Hetil; 2021 Mar; 162(162 Suppl 1):14-21. PubMed ID: 33774604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic characterization of the human relapsing fever spirochete Borrelia miyamotoi in vectors and animal reservoirs of Lyme disease spirochetes in France.
    Cosson JF; Michelet L; Chotte J; Le Naour E; Cote M; Devillers E; Poulle ML; Huet D; Galan M; Geller J; Moutailler S; Vayssier-Taussat M
    Parasit Vectors; 2014 May; 7():233. PubMed ID: 24886071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global economic burden of Chagas disease: a computational simulation model.
    Lee BY; Bacon KM; Bottazzi ME; Hotez PJ
    Lancet Infect Dis; 2013 Apr; 13(4):342-8. PubMed ID: 23395248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lyme borreliosis in Belgium: a cost-of-illness analysis.
    Geebelen L; Devleesschauwer B; Lernout T; Tersago K; Parmentier Y; Van Oyen H; Speybroeck N; Beutels P
    BMC Public Health; 2022 Nov; 22(1):2194. PubMed ID: 36443755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Are the Costs of Diagnostics and Treatment of Lyme Borreliosis in Poland?
    Rogalska AM; Pawełczyk O; Solarz K; Holecki T
    Front Public Health; 2020; 8():599239. PubMed ID: 33537276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Texas Occurrence of Lyme Disease and Its Neurological Manifestations.
    Dandashi JA; Nizamutdinov D; Dayawansa S; Fonkem E; Huang JH
    J Neuroinfect Dis; 2016 Jun; 7(2):. PubMed ID: 27478852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ-induced protein 10 in Lyme disease.
    Fallahi P; Elia G; Bonatti A
    Clin Ter; 2017; 168(2):e146-e150. PubMed ID: 28383628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis.
    Kastner RJ; Sicuri E; Stone CM; Matwale G; Onapa A; Tediosi F
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005934. PubMed ID: 28949987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive multiplex PCR assay to differentiate Lyme spirochetes and emerging pathogens Anaplasma phagocytophilum and Babesia microti.
    Chan K; Marras SA; Parveen N
    BMC Microbiol; 2013 Dec; 13():295. PubMed ID: 24359556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Lyme Disease in the United States and Europe.
    Marques AR; Strle F; Wormser GP
    Emerg Infect Dis; 2021 Aug; 27(8):2017-2024. PubMed ID: 34286689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Projected impact of population aging on non-communicable disease burden and costs in the Kingdom of Saudi Arabia, 2020-2030.
    Boettiger DC; Lin TK; Almansour M; Hamza MM; Alsukait R; Herbst CH; Altheyab N; Afghani A; Kattan F
    BMC Health Serv Res; 2023 Dec; 23(1):1381. PubMed ID: 38066590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive prevalence, reproductive health and our common future.
    Diczfalusy E
    Contraception; 1991 Mar; 43(3):201-27. PubMed ID: 2036793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Lyme Disease and Co-infections: Differential Diagnosis.
    Berghoff W
    Open Neurol J; 2012; 6():158-78. PubMed ID: 23400696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expanding Lyme Borrelia complex--clinical significance of genomic species?
    Stanek G; Reiter M
    Clin Microbiol Infect; 2011 Apr; 17(4):487-93. PubMed ID: 21414082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprophylaxis for Lyme borreliosis?
    Stanek G; Kahl O
    Zentralbl Bakteriol; 1999 Dec; 289(5-7):655-65. PubMed ID: 10652724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The health care costs of diabetic nephropathy in the United States and the United Kingdom.
    Gordois A; Scuffham P; Shearer A; Oglesby A
    J Diabetes Complications; 2004; 18(1):18-26. PubMed ID: 15019595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.